<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0702221679
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2016
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LOVRAK 200 mg suspension
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ACYCLOVIR
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        40
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        120
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        71.95
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        D06BB03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Lovrak</strong> suspension contains a medicine called acyclovir. This belongs to a group of medicines called antivirals. It works by stopping the growth of viruses.</p><p><strong><u>Lovrak can be used to:</u></strong></p><p>&sect; treat chickenpox</p><p>&sect; treat shingles, and when started right after the rash appears, it can help reduce the nerve pain that can exist after the shingles rash has cleared</p><p>&sect; treat cold sores and genital herpes and other herpes simplex infections (but not to be used to treat herpes simplex infections in new born infants or severe herpes simplex infections in children whose immune systems work less well which means their bodies are less able to fight infections)</p><p>&sect; stop cold sores and genital herpes returning after you have had them</p><p>&sect; prevent cold sores and genital herpes in people whose immune systems work less well</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Lovrak if:</strong></p><p>&sect; you are allergic (hypersensitive) to acyclovir or valacyclovir or any of the other ingredients (listed in section no. 6)</p><p>Do not take <strong>Lovrak</strong> if the above applies to you. If you are not sure, check with your doctor or pharmacist before taking <strong>Lovrak</strong>.</p><p><strong>Warnings and precautions</strong></p><p>Check with your doctor or pharmacist before taking <strong>Lovrak </strong>if:</p><p>&sect; you have kidney problems</p><p>&sect; you are over 65 years of age</p><p>&sect; you are thirsty. You must make sure you drink plenty of liquids such as water whilst taking this medicine.</p><p>&sect; your immune system is weak</p><p>If you are not sure if the above apply to you, check with your doctor or pharmacist before taking <strong>Lovrak</strong>.</p><p><strong>Children</strong></p><p>There is no data available to support the use of this medicine in stopping cold sores and genital herpes returning after having had them and treatment of shingles in children whose immune systems work well.</p><p><strong>Other medicines and Lovrak &nbsp;</strong></p><p>Tell your doctor or pharmacist if you are taking or have recently taken any other medicines. This includes medicines obtained without a prescription, including herbal medicines.</p><p>In particular tell your doctor or pharmacist if you are taking any of the following medicines:</p><p>&sect; probenecid, used to treat gout</p><p>&sect; cimetidine, used to treat stomach ulcers</p><p>&sect; mycophenolate mofetil, used to stop your body rejecting transplanted organs.</p><p><strong>Taking Lovrak with food and drink</strong></p><p>Food and drink should not affect the absorption of your medicine.</p><p><strong>Pregnancy, breast-feeding and fertility </strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>The ingredients in <strong>Lovrak </strong>can pass into breast milk. If you are breast-feeding, you must check with your doctor before you take <strong>Lovrak</strong>.&nbsp;</p><p><strong>Driving and using machines </strong></p><p>Some side effects such as feeling drowsy or sleepy may impair your ability to concentrate and react. Make sure you are not affected before you drive or operate machinery.</p><p><strong>Important information about some of the other ingredients of</strong> <strong>Lovrak</strong></p><p><strong>Lovrak </strong>contains sorbitol. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p><p><strong>Lovrak </strong>also contains Methyl paraben, propyl paraben which may cause allergic reactions (possibly delayed).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take <strong>Lovrak</strong> exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong><u>Taking this medicine</u></strong></p><p>&sect; Take this medicine by mouth.</p><p>&sect; Use the measuring cup provided to carefully measure the dose needed.</p><p>&sect; Start to take <strong>Lovrak</strong> as soon as possible.</p><p>&sect; Drink plenty of liquids such as water while taking this medicine.</p><p>The dose that you should take will depend on what you have been given <strong>Lovrak</strong> for. Your doctor will discuss this with you.</p><p><strong><u>Adults</u></strong></p><p><strong>Treatment of chickenpox and shingles</strong></p><p>&sect; The usual dose is 4 teaspoonfuls (20mL) 5 times a day.</p><p>&sect; You should space each dose by 4 hours.</p><p>&sect; Suggested times are: <strong>7 am</strong>,<strong> 11 am</strong>,<strong> 3 pm</strong>,<strong> 7 pm and 11 pm</strong>.</p><p>&sect; You should take <strong>Lovrak</strong> for 7 days.</p><p><strong>Treatment of cold sores and genital herpes</strong></p><p>&sect; The usual dose is one teaspoonful (5mL) 5 times a day.</p><p>&sect; You should space each dose by 4 hours.</p><p>&sect; Suggested times are: <strong>7 am</strong>,<strong> 11 am</strong>,<strong> 3 pm</strong>,<strong> 7 pm and 11 pm</strong>.</p><p>&sect; You should take <strong>Lovrak</strong> for 5 days or longer if your doctor tells you to.</p><p><strong>Stopping these problems returning after you have had them </strong></p><p>&sect; The usual dose is one teaspoonful (5mL) 4 times a day.</p><p>&sect; You should try to space each dose by 6 hours.</p><p>&sect; You should take <strong>Lovrak</strong> until your doctor tells you to stop.</p><p><strong>Preventing these problems in people whose immune systems work less well </strong></p><p>&sect; The usual dose is one teaspoonful (5mL) 4 times a day. Your doctor may decide to double the dose to two teaspoonfuls (10mL) 4 times daily in people whose immune systems are severely impaired.</p><p>&sect; You should try to space each dose by 6 hours.</p><p>&sect; You should take <strong>Lovrak</strong> until your doctor tells you to stop.</p><p>&sect; Your doctor may decide to increase the dose or give a different form of this medicine by intravenous infusion</p><p><strong><u>Children</u></strong></p><p>Your doctor may adjust the dose of <strong>Lovrak</strong> if it is for a child.</p><p>There is no data available to support the use of this medicine in stopping cold sores and genital herpes returning after having had them and treatment of shingles in children whose immune systems work well.</p><p><strong>Treatment of cold sores and genital herpes:</strong></p><p>&sect; 2 years and over: one teaspoonful (5mL) five times a day.</p><p>&sect; Under 2 years: half teaspoonful (2.5mL) five times a day.</p><p><strong>Preventing these problems in children whose immune systems work less:</strong></p><p>&sect; 2 years and over: one teaspoonful (5mL) four times a day.</p><p>&sect; Under 2 years: half teaspoonful (2.5mL) four times a day.</p><p><strong>Treatment of chicken pox</strong></p><p>&sect; 6 years and over: 4 teaspoonful (20mL) four times a day</p><p>&sect; 2-5 years: 2 teaspoonful (10mL) four times a day</p><p>&sect; Under 2 years: 1 teaspoonful (5mL) &nbsp;four times a day</p><p>&sect; You should try to space each dose by 5 hours. Suggested times are: <strong>7am, 12noon, 5pm and 10pm.</strong></p><p>&sect; Your child should take <strong>Lovrak</strong> for five days</p><p><strong>Your doctor may adjust the dose of Lovrak if:</strong></p><p>&sect; you are over 65 years of age</p><p>&sect; you have kidney problems.</p><p><strong>People over 65 years of age or with kidney problems: </strong></p><p><strong>It is very important while you are taking Lovrak that you drink water regularly</strong> during the day. This will help to reduce side effects that can affect the kidney or nervous system. Your doctor will closely monitor you for signs of these. Nervous system side effects might include feeling confused or agitated, or feeling unusually sleepy or drowsy.</p><p>Talk to your doctor before taking <strong>Lovrak</strong> if any of the above apply.</p><p><strong>If you take more Lovrak than you should</strong></p><p><strong>Lovrak</strong> is not usually harmful, unless you take too much over several days. Talk to your doctor or pharmacist if you take too much <strong>Lovrak</strong>. Take the medicine pack with you.</p><p><strong>If you forget to take Lovrak</strong></p><p>If you forget to take <strong>Lovrak</strong>, take a dose as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose.</p><p>Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you have any further questions on the use of this product, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <strong>Lovrak</strong> can cause side effects, although not everybody gets them.</p><p>The following side effects may happen with this medicine:</p><p><strong>Allergic reactions </strong>(may affect up to1 in 1,000 people)</p><p>If you have an allergic reaction, <strong>stop taking Lovrak and see a doctor straight away</strong>.</p><p>The signs may<strong> </strong>include:</p><p>&sect; bumpy rash, itching or hives on your skin</p><p>&sect; swelling of your face, lips, tongue or other parts of your body (angioedema)</p><p>&sect; shortness of breath, wheezing or trouble breathing</p><p>&sect; unexplained fever (high temperature) and feeling faint, especially when standing up.</p><p>Other side effects include:</p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><p>&sect; headache</p><p>&sect; feeling dizzy</p><p>&sect; feeling or being sick</p><p>&sect; diarrhoea</p><p>&sect; stomach pains</p><p>&sect; skin reaction after exposure to light (photosensitivity)</p><p>&sect; itching</p><p>&sect; feeling tired (fatigue)</p><p>&sect; fever</p><p><strong>Uncommon </strong>(may affect up to<strong> </strong>1 in 100 people)</p><p>&sect; bumpy, itchy, hive-like rash (urticarial)</p><p>&sect; hair loss</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>&sect; difficulty breathing</p><p>&sect; effects on some blood and urine tests including changes in the levels of liver enzymes and blood count changes</p><p>&sect; swelling of your face, lips, mouth, tongue or throat (angioedema).</p><p><strong>Very rare </strong>(may affect up to 1 in 10,000 people)</p><p>&sect; nosebleeds and bruising more easily than usual as a result of reduced numbers in blood platelets (thrombocytopenia)</p><p>&sect; reduction in the number of red blood cells (anaemia) and white blood cells (leukopenia)</p><p>&sect; feeling agitated or confused</p><p>&sect; shaking or tremors</p><p>&sect; hallucinations (seeing or hearing things that aren&rsquo;t there)</p><p>&sect; fits (seizures)</p><p>&sect; feeling unusually sleepy or drowsy</p><p>&sect; unsteadiness when walking and lack of co-ordination (ataxia)</p><p>&sect; difficulty speaking or hoarseness (dysarthria)</p><p>&sect; inability to think or judge clearly or concentrate</p><p>&sect; unconsciousness (coma)</p><p>&sect; disturbances of behaviour, speech and bodily movements</p><p>&sect; damage or malfunction of the brain (encephalopathy) which is evident by an altered mental state</p><p>&sect; inflammation of the liver (hepatitis)</p><p>&sect; yellowing of your skin and whites of your eyes (jaundice)</p><p>&sect; kidney problems where you pass little or no urine</p><p>&sect; pain in your lower back, the kidney area of your back or just above your hip (renal pain).</p><p>&sect; fatigue, decreased energy, weakness, shortness of breath, light-headedness, palpitations, looking pale (anaemia)</p><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</strong></p><p><strong><u>To report any side effect(s):</u></strong></p><p>&sect; <strong>Saudi Arabia:</strong></p><p><strong>The National Pharmacovigilance and Drug Safety Center (NPC)</strong></p><p><strong>Fax: </strong>+966-11-205-7662</p><p><strong>Call NPC at </strong>+966-11-2038222, <strong>Exts: </strong>2317-2356-2340.</p><p><strong>Reporting Hotline: </strong>19999</p><p><strong>E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>Website: </strong>www.sfda.gov.sa/npc</p><p>&sect; <strong>Other GCC States: </strong>Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp;&nbsp;&nbsp; Store below 30&deg;C.<em> </em>After opening, use within one month.</p><p>-&nbsp;&nbsp;&nbsp; Do not take <strong>Lovrak</strong> after the expiry date which is stated on the carton and on the inner label. The expiry date (Exp.) refers to the last day of that month.</p><p>-&nbsp;&nbsp;&nbsp; Do not take <strong>Lovrak</strong> if you notice any visible sign of deterioration.</p><p>-&nbsp;&nbsp;&nbsp; Medicines should not be disposed off via wastewater or household waste. Ask your pharmacist how to dispose off medicines no longer required. These measures will help to protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is acyclovir. Each teaspoonful (5mL) of the suspension contains 200mg of acyclovir.</p><p>Other ingredients: Methyl paraben, propyl paraben, microcrystalline cellulose, glycerol, sorbitol 70% solution, orange banana flavour and purified water.<strong> </strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Lovrak suspension is available in packs of 1 bottle (120mL) each.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot;Julphar&quot;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                06/01/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي معلق <strong>لفراك </strong>على المادة الفعالة أسيكلوفير التي تنتمي إلى مجموعة من الأدوية تعرف باسم الأدوية المضادة للفيروسات، وهي تعمل عن طريق إيقاف نمو الفيروسات.</p><p dir="RTL"><strong><u>يستخدم لفراك في الحالات التالية:</u></strong></p><p dir="RTL">&sect;&nbsp; علاج الجديري المائي</p><p dir="RTL">&sect;&nbsp; علاج الهربس النطاقي وعند ظهوره مباشرة من حدوث الطفح الجلدي، بإمكان <strong>لفراك </strong>المساعدة على تقليل آلام الأعصاب التي يمكن أن تحدث بعد اختفاء الطفح الجلدي&nbsp;الناتج عن&nbsp;الهربس النطاقي&nbsp;</p><p dir="RTL">&sect;&nbsp; لعلاج الهربس الفموي (قرحة البرد)، الهربس التناسلي أو الحالات الأخرى من عدوى الهربس البسيط (ولكن لا يستخدم لعلاج حالات عدوى الهربس البسيط لدى الأطفال حديثي الولادة أو الحالات الشديدة من عدوى الهربس البسيط لدى الأطفال الذي يعانون من ضعف في الجهاز المناعي، مما يعني أنهم ليس لديهم القدرة الكافية على مقاومة العدوى)</p><p dir="RTL">&sect;&nbsp; الحد من معاودة حدوث الهربس الفموي (قرحة البرد) والهربس التناسلي بعد الإصابة بها</p><p dir="RTL">&sect;&nbsp; الوقاية من حدوث الهربس الفموي (قرحة البرد) والهربس التناسلي لدى الأشخاص الذين يعانون من ضعف في الجهاز المناعي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عليك عدم تناول لفراك في الحالات التالية:</strong></p><p dir="RTL">&sect;&nbsp; إذا كنت تعاني من الحساسية (فرط الحساسية) تجاه أسيكلوفير أو فالاسيكلوفير أو تجاه أياً من المواد الغير فعالة الأخرى (انظر بند رقم 6).</p><p dir="RTL">يجب عدم تناول <strong>لفراك</strong> إذا كان مما ذكر أعلاه ينطبق عليك. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>لفراك</strong>، ما لم تكن متأكداً من ذلك.</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>لفراك</strong> في الحالات التالية:</p><p dir="RTL">&sect;&nbsp; إذا كنت تعاني من مشاكل في الكلى</p><p dir="RTL">&sect;&nbsp; إذا كنت بعمر أكبر من 65 عاماً</p><p dir="RTL">&sect;&nbsp; إذا كنت تشعر بالعطش. يجب عليك الحرص على تناول كمية كافية من السوائل على سبيل المثال الماء أثناء فترة تناول هذا الدواء.</p><p dir="RTL">&sect;&nbsp; إذا كنت تعاني من ضعف في الجهاز المناعي</p><p dir="RTL">يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>لفراك</strong>، في حال لم تكن متأكداً من أن أي مما ذكر أعلاه ينطبق عليك.</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">لا تتوفر معلومات كافية تدعم استعمال هذا الدواء للحد من معاودة حدوث الهربس الفموي (قرحة البرد) والهربس التناسلي بعد الإصابة بها وعلاج الهربس النطاقي لدى الأطفال الذين يعانون من ضعف في الجهاز المناعي.</p><p dir="RTL"><strong>تناول الأدوية الأخرى بالتزامن مع لفراك</strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول أو تناولت مؤخراً أية أدوية أخرى. بما في ذلك الأدوية التي تصرف دون وصفة طبية والأدوية العشبية.</p><p dir="RTL">بصفة خاصة، يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول أياً من الأدوية التالية:</p><p dir="RTL">&sect;&nbsp; بروبنسيد، دواء يستخدم لعلاج النقرس</p><p dir="RTL">&sect;&nbsp; سيميتدين، دواء يستخدم لعلاج قرحات المعدة</p><p dir="RTL">&sect;&nbsp; مايكوفينولات موفيتيل، دواء يستخدم لمنع رفض الجسم الأعضاء المزروعة.</p><p dir="RTL"><strong>لفراك مع الطعام والشراب</strong></p><p dir="RTL">لا يؤثر الطعام أو الشراب على امتصاص هذا الدواء في الجسم.</p><p dir="RTL"><strong>الحمل، الرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعاملين معه للحصول على المشورة الطبية قبل تناول هذا الدواء، إذا كنت حاملاً أو ترضعين طفلك رضاعة طبيعية، تعتقدين أنك حاملاً أو تخططين لكي تصبحين حاملاً.</p><p dir="RTL">من الممكن أن تفرز المواد في<strong> لفراك </strong>في حليب الثدي. يرجى منك استشارة طبيبك المعالج قبل تناول <strong>لفراك</strong>، إذا كنت ترضعين طفلك رضاعة طبيعية. &nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد تؤثر بعض التأثيرات الجانبية على سبيل المثال الشعور بالنعاس على قدرتك على التركيز وعلى نشاطك اليومي. احرص على أن تكون بحالة صحية جيدة قبل القيادة أو تشغيل الآلات.</p><p dir="RTL"><strong>معلومات هامة عن بعض المكونات الأخرى في لفراك</strong></p><p dir="RTL">يحتوي <strong>لفراك</strong> على سوربيتول. يرجى منك استشارة طبيبك المعالج قبل تناول هذا الدواء إذا كان قد أخبرك مسبقاً بأنك تعاني من مشكلة تتمثل في عدم القدرة على تحمل بعض أنواع السكر.</p><p dir="RTL">كما يحتوي <strong>لفراك</strong> على ميثيل البارابين وبروبيل البارابين اللذان قد يتسببا في حدوث التفاعلات التحسسية (يحتمل حدوثها بصورة متأخرة).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك دائماً تناول <strong>لفراك </strong>بدقة وفقاً لتعليمات طبيبك المعالج. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه ما لم تكن متأكداً من كيفية تناول هذا الدواء.</p><p dir="RTL"><strong><u>حول تناول هذا الدواء</u></strong></p><p dir="RTL">&sect;&nbsp; تناول هذا الدواء عن طريق الفم.</p><p dir="RTL">&sect;&nbsp; قم باستخدام كوب المعايرة المرفق مع هذا الدواء لقياس الجرعة الواجب تناولها بدقة.</p><p dir="RTL">&sect;&nbsp; يجب عليك البدء في تناول <strong>لفراك</strong> في أسرع وقت ممكن.</p><p dir="RTL">&sect;&nbsp; يجب عليك تناول كمية كافية من السوائل على سبيل المثال الماء أثناء فترة تناول هذا الدواء.</p><p dir="RTL">يعتمد مقدار الجرعة الواجب تناولها على نوع العدوى التي تم وصف العلاج لها، وسيوضح لك الطبيب المعالج ذلك إذا لزم الأمر.</p><p dir="RTL"><strong><u>البالغين</u></strong></p><p dir="RTL"><strong>علاج الجديري المائي والهربس النطاقي </strong></p><p dir="RTL">&sect;&nbsp; يبلغ مقدار الجرعة الاعتيادية 4 ملاعق صغيرة (20 ملليلتر) 5 مرات يومياً.</p><p dir="RTL">&sect;&nbsp; يجب ترك 4 ساعات فاصلة بين كل جرعة والأخرى.</p><p dir="RTL">&nbsp;&nbsp; الأوقات المقترحة لتناول الدواء خلال اليوم هي: <strong>7 صباحاً، 11 صباحاً، 3 مساءً، 7 مساءً و11 مساءً</strong>.</p><p dir="RTL">&sect;&nbsp; يجب عليك تناول <strong>لفراك</strong> لمدة 7 أيام.</p><p dir="RTL"><strong>علاج الهربس الفموي (قرحة البرد) </strong><strong>والهربس التناسلي</strong></p><p dir="RTL">&sect;&nbsp; يبلغ مقدار الجرعة الاعتيادية ملعقة صغيرة واحدة (5 ملليلتر) 5 مرات يومياً.</p><p dir="RTL">&sect;&nbsp; يجب ترك 4 ساعات فاصلة بين كل جرعة والأخرى.</p><p dir="RTL">&sect;&nbsp; الأوقات المقترحة لتناول الدواء خلال اليوم هي: <strong>7 صباحاً، 11 صباحاً، 3 مساءً، 7 مساءً و11 مساءً.</strong></p><p dir="RTL">&sect;&nbsp; يجب عليك تناول <strong>لفراك</strong> لمدة 5 أيام أو أكثر إذا أخبرك طبيبك المعالج بذلك.</p><p dir="RTL"><strong>للحد من معاودة حدوث </strong><strong>الهربس الفموي (قرحة البرد) </strong><strong>والهربس التناسلي بعد الإصابة بها</strong></p><p dir="RTL">&sect;&nbsp; يبلغ مقدار الجرعة الاعتيادية ملعقة صغيرة واحدة (5 ملليلتر) 4 مرات يومياً.</p><p dir="RTL">&sect;&nbsp; يجب عليك ترك 6 ساعات فاصلة بين كل جرعة والأخرى.</p><p dir="RTL">&sect;&nbsp; يجب عليك الاستمرار في تناول <strong>لفراك</strong> إلى أن يخبرك طبيبك المعالج بالتوقف عن تناوله.</p><p dir="RTL"><strong>الوقاية من حدوث </strong><strong>الهربس الفموي (قرحة البرد) والهربس التناسلي </strong><strong>لدى الأشخاص الذين يعانون من ضعف في الجهاز المناعي </strong></p><p dir="RTL">&sect;&nbsp; يبلغ مقدار الجرعة الاعتيادية ملعقة صغيرة واحدة (5 ملليلتر) 4 مرات يومياً. قد يقوم طبيبك المعالج بمضاعفة مقدار الجرعة إلى ملعقتين صغيرتين (10 ملليلتر) 4 مرات يومياً للأشخاص الذين يعانون من ضعف شديد في الجهاز المناعي.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; يجب ترك 6 ساعات فاصلة بين كل جرعة والأخرى.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; يجب عليك الاستمرار في تناول <strong>لفراك</strong> إلى أن يخبرك طبيبك المعالج بالتوقف عن تناوله.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; قد يقوم طبيبك المعالج إلى زيادة مقدار الجرعة أو إعطاء شكل صيدلاني آخر من هذا الدواء عن طريق التسريب الوريدي.</p><p dir="RTL"><strong><u>الأطفال</u></strong></p><p dir="RTL">قد يقوم طبيبك المعالج بتعديل مقدار الجرعة، في حال إعطاء هذا الدواء للمرضى من فئة الأطفال.</p><p dir="RTL">لا تتوفر معلومات كافية تدعم استعمال هذا الدواء للحد من معاودة حدوث الهربس الفموي (قرحة البرد) والهربس التناسلي بعد الإصابة بها وعلاج الهربس النطاقي لدى الأطفال الذين يعانون من ضعف في الجهاز المناعي.</p><p dir="RTL"><strong>علاج الهربس الفموي (قرحة البرد) </strong><strong>والهربس التناسلي:</strong></p><p dir="RTL">&sect;&nbsp; الأطفال بعمر سنتين فما فوق: ملعقة صغيرة واحدة (5 ملليلتر) 5 مرات يومياً.</p><p dir="RTL">&sect;&nbsp; الأطفال بعمر أقل من سنتين: نصف ملعقة صغيرة (2,5 ملليلتر) 5 مرات يومياً.</p><p dir="RTL"><strong>الوقاية من حدوث </strong><strong>الهربس الفموي (قرحة البرد) والهربس التناسلي </strong><strong>لدى الأطفال الذين يعانون من ضعف في الجهاز المناعي: </strong></p><p dir="RTL">&sect;&nbsp; الأطفال بعمر سنتين فما فوق: ملعقة صغيرة واحدة (5 ملليلتر) 4 مرات يومياً.</p><p dir="RTL">&sect;&nbsp; الأطفال بعمر أقل من سنتين: نصف ملعقة صغيرة (2,5 ملليلتر) 4 مرات يومياً.</p><p dir="RTL"><strong>علاج الجديري المائي</strong></p><p dir="RTL">&sect;&nbsp; الأطفال بعمر 6 سنوات فما فوق: 4 ملاعق صغيرة (20 ملليلتر) 4 مرات يومياً.</p><p dir="RTL">&sect;&nbsp; الأطفال بعمر يتراوح ما بين 2 إلى 5 سنوات: ملعقتين صغيرتين (10 ملليلتر) 4 مرات يومياً</p><p dir="RTL">&sect;&nbsp; الأطفال بعمر أقل من سنتين: ملعقة صغيرة واحدة (5 ملليلتر) 4 مرات يومياً.</p><p dir="RTL">&sect;&nbsp; يجب ترك 5 ساعات فاصلة بين كل جرعة والأخرى.</p><p dir="RTL">الأوقات المقترحة لتناول الدواء خلال اليوم هي: <strong>7 صباحاً، 12 منتصف النهار، 5 مساءً و10 مساءً</strong>.</p><p dir="RTL">&sect;&nbsp; يجب إعطاء طفلك <strong>لفراك </strong>لمدة خمسة أيام</p><p dir="RTL"><strong>قد يقوم طبيبك المعالج بإجراء تعديل على مقدار جرعة لفراك في الحالات التالية:</strong></p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; إذا كنت بعمر أكبر من 65 عاماً</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في الكلى.</p><p dir="RTL"><strong>الأشخاص بعمر أكبر من 65 عاماً أو الذين يعانون من مشاكل في الكلى </strong></p><p dir="RTL"><strong>يعد تناول الماء بصورة منتظمة خلال اليوم أثناء فترة تلقي العلاج باستخدام </strong><strong>لفراك أمراً هاماً. </strong>يساعد ذلك في تقليل حدوث التاثيرات الجانبية التي تصيب الكلى أو الجهاز العصبي. سوف يقوم طبيبك المعالج بمراقبة حدوث هذه العلامات لديك بدقة. قد تتضمن علامات التأثيرات الجانبية التي تصيب الجهاز العصبي على الشعور بالارتباك أو هياج أو الشعور بالنعاس على نحو غير معتاد.&nbsp;</p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج قبل تناول <strong>لفراك</strong> إذا كانت أياً من هذه الحالات المذكورة أعلاه تنطبق عليك.</p><p dir="RTL"><strong>إذا تناولت لفراك بجرعة أكبر مما يجب </strong></p><p dir="RTL">عادةً لا يتسبب <strong>لفراك </strong>في حدوث أية أضرار، إلا إذا كنت تناوله بصورة مفرطة على مدى عدة أيام. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت قد تناولت <strong>لفراك</strong> بصورة مفرطة مع أخذ عبوة الدواء معك.</p><p dir="RTL"><strong>إذا سهوت عن تناول لفراك</strong></p><p dir="RTL">إذا سهوت عن تناول إحدى جرعات <strong>لفراك،</strong> فيجب عليك تناولها في أسرع&nbsp; وقت ممكن حال تذكرها. على الرغم من ذلك، في حال اقتراب موعد تناول الجرعة التالية، فيجب عليك التخطي عن تناول الجرعة التي قد سهوت عن تناولها.</p><p dir="RTL">يجب عدم تناول جرعة مضاعفة لتعويض عن الجرعات المفردة التي قد سهوت عن تناولها.</p><p dir="RTL"><strong>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كان لديك أية أسئلة إضافية حول استعمال هذا الدواء. </strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن جميع الأدوية، قد يؤدي<strong> لفراك </strong>إلى حدوث تأثيرات جانبية، ولكنها قد لا تحدث لكل شخص.</p><p dir="RTL">قد تحدث التأثيرات الجانبية التالية أثناء فترة استعمال هذا الدواء:</p><p dir="RTL"><strong>تفاعلات تحسسية</strong> ( قد تصيب ما يصل إلى شخص واحد من كل 1000 شخص)</p><p dir="RTL"><strong>يرجى منك التوقف عن تناول لفراك واستشارة الطبيب المعالج على الفور</strong>، إذا كنت تعاني من أية تفاعلات تحسسية.</p><p dir="RTL">قد تتضمن علامات التفاعلات التحسسية على ما يلي:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; طفح جلدي مصحوباُ بنتوءات تحت الجلد، حكة أو طفح جلدي على شكل خلايا النحل</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; تورم الوجه، الشفتين، اللسان أو أجزاء أخرى من الجسم (وذمة وعائية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; ضيق التنفس، أزيز أو مشاكل في التنفس</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; حمى غير معروفة السبب (ارتفاع درجة الحرارة الجسم) والشعور على وشك الإغماء، وبصفة خاصة عند الوقوف</p><p dir="RTL">تتضمن التأثيرات الجانبية الأخرى على:</p><p dir="RTL"><strong>شائعة </strong>(قد تصيب ما يصل إلى شخص واحد من كل 10 أشخاص)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; شعور بالدوخة</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; شعور بالإعياء أو توعك</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; إسهال</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; آلام في المعدة</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; حدوث تفاعلات جلدية بعد التعرض للضوء (حساسية تجاه الضوء)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; حكة</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; الشعور بالتعب</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; حمى.</p><p dir="RTL"><strong>غير شائعة </strong>(قد تصيب ما يصل إلى شخص واحد من كل 100 شخص)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; طفح جلدي على شكل خلايا النحل مصحوباً بحكة ونتوءات جلدية (شرى)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; فقدان الشعر</p><p dir="RTL"><strong>نادرة</strong> (قد تصيب ما يصل إلى شخص واحد من كل 1000 شخص)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; ضيق في التنفس</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; ظهور بعض التأثيرات على نتائج فحوصات الدم والبول بما في ذلك تغيرات في مستويات إنزيمات الكبد وتعداد الدم</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; تورم الوجه، الشفتين، الفم، اللسان أو الحلق (وذمة وعائية)</p><p dir="RTL"><strong>نادرة جداً</strong> (قد تصيب ما يصل إلى شخص واحد من كل 10000 شخص)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; حدوث نزيف من الأنف وظهور الكدمات بصورة أسهل من المعتاد، نظراً لانخفاض تعداد الصفائح الدموية (قلة الصفيحات)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; انخفاض تعداد خلايا الدم الحمراء (فقر الدم) وانخفاض تعداد خلايا الدم البيضاء (قلة الكريات البيض)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; الشعور بالهياج أو الارتباك</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; اشعور بالارتعاش أو الاهتزاز</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; الهلوسة (رؤية أو سماع أشياء وهمية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; نوبات تشنجية (اختلاجات)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; الشعور بالنعاس على نحو غير معتاد</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; الترنح أثناء المشي وعدم تناسق الحركة</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; صعوبة في الكلام أو بحة في الصوت (عسر التلفظ)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; عدم القدرة على التفكير أو اتخاذ القرار بوضوح أو التركيز</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; فقدان الوعي (الغيبوبة)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; اضطرابات في السلوك والكلام والحركات الجسدية</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; تلف أو اضطراب وظائف الدماغ (اعتلال الدماغ) الذي يتمثل في حدوث تغيرات الحالة العقلية</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; التهاب الكبد</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; اصفرار الجلد وبياض العينين (اليرقان)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; مشاكل في الكلى التي تتمثل في قلة التبول أوعدم التبول</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; ألم في أسفل الظهر، منطقة الكلى من الجهة الخلفية في منطقة الظهر أو مباشرة فوق الفخذ (الألم الكلوي)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp; الشعور بالتعب، قلة النشاط، الشعور بالضعف، ضيق التنفس، الشعور بالدوار، خفقان، شحوب الجلد (فقر الدم)</p><p dir="RTL"><strong>يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه، في </strong><strong>حال زيادة حدة التأثيرات الجانبية</strong><strong> أو إذا لاحظت حدوث أية تأثيرات جانبية أخرى ولم </strong><strong>ي</strong><strong>تم ذكرها في هذه النشرة. </strong></p><p dir="RTL"><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong></p><p dir="RTL"><strong>&sect;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية</strong></p><p dir="RTL"><strong>المركز</strong><strong> الوطني للتيقظ والسلامة الدوائية</strong></p><p dir="RTL"><strong>رقم الفاكس: </strong>&nbsp;&nbsp;7662-205-11-966+</p><p dir="RTL"><strong>يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على: </strong>2038222-11-966+</p><p dir="RTL"><strong>وصلة</strong><strong> هاتف:</strong>2340-2356-2317</p><p dir="RTL"><strong>الخط</strong><strong> الساخن: </strong>19999</p><p dir="RTL"><strong>البريد</strong><strong> الإلكتروني:</strong><strong> </strong><strong>&nbsp;</strong>npc.drug@sfda.gov.sa</p><p dir="RTL"><strong>الموقع الإلكتروني: </strong>www.sfda.gov.sa/npc</p><p dir="RTL"><strong>&sect;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول مجلس التعاون الخليجي الأخرى: </strong>يرجى الاتصال بالجهات المختصة ذات الصلة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من30 &ordm;م. بعد فتح العبوة، يستخدم خلال شهر واحد.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>لفراك </strong>بعد تاريخ انتهاء الصلاحية المذكور على العبوة والملصق الداخلي للزجاجة.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">يشير تاريخ انتهاء الصلاحية إلى آخر يوم من الشهر المذكور.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>لفراك</strong> إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي أسيكلوفير. تحتوي كل ملعقة صغيرة (5 ملليلتر) من المعلق على 200 ملغم من أسيكلوفير.</p><p dir="RTL">المواد الأخرى: ميثيل البارابين، بروبيل البارابين، سليلوز دقيق البلورات، جليسيرول، محلول السوربتول 70٪، نكهة الموز والبرتقال &nbsp;وماء منقى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتوفر <strong>لفراك </strong>في عبوات تحتوي كلاً منها على زجاجة واحدة (سعة 120 ملليلتر).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            06/01/2020م
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lovrak 200mg/5mL Oral Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each teaspoonful (5mL) of the suspension contains:
Item No. Material Name Scale (mg/5mL)
Active Ingredient:
1. Acyclovir 200.00
Use: Acyclovir USP* 212.00
Inactive Ingredients:
1. Methyl Paraben 5.00
2. Propyl Paraben 1.00
3. Avicel RC 591 75.00
4. Glycerol 750.00
5. Sorbitol 70% Solution 2250.00
6. Orange Banana Flavour 20.00
7. Purified Water q.s to 5mL
* Calculated considering the water content (water content NMT
6.0%)
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral Suspension
Description: White to off-white, viscous, homogeneous suspension
with orange-banana flavour and sweet palatable taste, free from
foreign matter.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Lovrak Suspension is indicated for the treatment of herpes simplex<br />virus infections of the skin and mucous membranes including initial<br />and recurrent genital herpes (excluding neonatal HSV and severe<br />HSV infections in immunocompromised children).<br />Lovrak Suspension is indicated for the suppression (prevention of<br />recurrences) of recurrent herpes simplex infections in<br />immunocompetent patients.<br />Lovrak Suspension is indicated for the prophylaxis of herpes<br />simplex infections in immunocompromised patients.<br />Lovrak Suspension is indicated for the treatment of varicella<br />(chickenpox) and herpes zoster (shingles) infections. Studies have<br />shown that early treatment of shingles with acyclovir has a<br />beneficial effect on pain and can reduce the incidence of postherpetic<br />neuralgia (zoster-associated pain).</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dosage for treatment of Herpes Simplex in Adults<br />For treatment of Herpes simplex infections, 200mg Lovrak should<br />be taken five times daily at approximately four-hourly intervals<br />omitting the night time dose. Treatment should continue for 5<br />days, but in severe initial infections may have to be extended.<br />In severely immunocompromised patients (e.g. after marrow<br />transplant) or in patients with impaired absorption from the gut<br />the dose can be doubled to 400mg Lovrak or, alternatively,<br />intravenous dosing could be considered.<br />Dosing should begin as early as possible after the start of an<br />infection; for recurrent episodes this should preferably be during<br />the prodromal period or when lesions first appear.<br />Dosage for suppression of Herpes simplex in adults<br />For suppression of Herpes simplex infections in immunocompetent<br />patients, 200mg Lovrak should be taken four times daily at<br />approximately six-hourly intervals.<br />Many patients may be conveniently managed on a regimen of<br />400mg Lovrak taken twice daily at approximately twelve-hourly<br />intervals.<br />Dosage titration down to 200mg Lovrak taken thrice daily at<br />approximately eight-hourly intervals or even twice daily at<br />approximately twelve-hourly intervals, may prove effective.<br />Some patients may experience break-through infections on total<br />daily doses of 800mg Lovrak.<br />Therapy should be interrupted periodically at intervals of six to<br />twelve months in order to observe possible changes in the natural<br />history of the disease.<br />Dosage for prophylaxis of Herpes simplex in adults<br />For prophylaxis of Herpes simplex infections in<br />immunocompromised patients, 200mg Lovrak should be taken<br />four times daily at approximately six-hourly intervals.<br />In severely immunocompromised patients (e.g. after marrow<br />transplant) or in patients with impaired absorption from the gut,<br />the dose can be doubled to 400mg Lovrak or, alternatively,<br />intravenous dosing could be considered.<br />The duration of prophylactic administration is determined by the<br />duration of the period at risk.<br />Dosage for treatment of Varicella and Herpes zoster in adults<br />For treatment of Varicella and Herpes zoster infections, 800 mg<br />Lovrak should be taken five times daily at approximately fourhourly<br />intervals, omitting the night time dose. Treatment should<br />continue for seven days.<br />In severely immunocompromised patients (e.g. after marrow<br />transplant) or in patients with impaired absorption from the gut,<br />consideration should be given to intravenous dosing.<br />Dosing should begin as early as possible after the start of the<br />infection; treatment yields better results if initiated as soon as<br />possible after onset of the rash.<br />Dosage for Infants and Children<br />For treatment of Herpes simplex infections, and prophylaxis of<br />Herpes simplex infections in the immunocompromised, children<br />aged two years and over should be given adult dosages. Infants<br />and children below the age of two years should be given half the<br />adult dose.<br />For treatment of varicella infections for infants and children:<br /> 6 years and over: 800 mg acyclovir four times daily<br /> 2 - &lt; 6 years: 400 mg acyclovir four times daily<br /> Under 2 years: 200 mg acyclovir four times daily<br />Treatment should continue for five days.<br />Dosing may be more accurately calculated as 20 mg/kg bodyweight<br />(not to exceed 800mg) acyclovir four times daily.<br />No specific data are available on the suppression of herpes simplex<br />infections or the treatment of herpes zoster infections in<br />immunocompetent children.</p><p>Dosage in the elderly: The possibility of renal impairment in the<br />elderly must be considered and the dosage should be adjusted<br />accordingly (see Dosage in renal impairment). Adequate hydration<br />should be maintained.<br />Dosage in renal impairment: Caution is advised when<br />administering acyclovir to patients with impaired renal function.<br />Adequate hydration should be maintained.<br />In the management of Herpes simplex infections in patients with<br />impaired renal function, the recommended oral doses will not lead<br />to accumulation of acyclovir above levels that have been<br />established by intravenous infusion. However, for patients with<br />severe renal impairment (creatinine clearance less than 10<br />mL/minute) an adjustment of dosage to 200mg twice daily at<br />approximately twelve-hourly intervals is recommended.<br />In the treatment of Varicella and Herpes zoster infections it is<br />recommended that the dosage be adjusted to 800mg twice daily at<br />approximately twelve-hourly intervals for patients with severe<br />renal impairment (creatinine clearance less than 10mL/minute),<br />and to 800mg three times daily at intervals of approximately eight<br />hours for patients with moderate renal impairment (creatinine</p><p>clearance in the range 10-25 mL/minute).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lovrak Suspension is contraindicated in patients known to be
hypersensitive to acyclovir and valacyclovir or to any of the
excipients as listed in section 6.1.
 Patients with rare hereditary problems of fructose intolerance
should not take this medicine.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Use in patients with renal impairment and in elderly patients:<br />Acyclovir is eliminated by renal clearance, therefore the dose must<br />be adjusted in patients with renal impairment (see section 4.2).<br />Elderly patients are likely to have reduced renal function and<br />therefore the need for dose adjustment must be considered in this<br />group of patients. Both elderly patients and patients with renal<br />impairment are at increased risk of developing neurological side<br />effects and should be closely monitored for evidence of these<br />effects. In the reported cases, these reactions were generally<br />reversible on discontinuation of treatment (see section 4.8).<br />Prolonged or repeated courses of acyclovir in severely immunecompromised<br />individuals may result in the selection of virus strains<br />with reduced sensitivity, which may not respond to continued<br />acyclovir treatment (see section 5.1).<br />Hydration status: Care should be taken to maintain adequate<br />hydration in patients receiving high oral doses of acyclovir.<br />Lovrak Suspension contains Methyl paraben and Propyl paraben<br />which may cause allergic reactions (possibly delayed).<br />Lovrak Suspension also contains sorbitol. Hence Patients with rare<br />hereditary problems of fructose intolerance should not take this<br />medicine.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinically significant interactions have been identified.<br />Acyclovir is eliminated primarily unchanged in the urine via active<br />renal tubular secretion. Any drugs administered concurrently that<br />compete with this mechanism may increase acyclovir plasma<br />concentrations. Probenecid and cimetidine increase the AUC of<br />acyclovir by this mechanism, and reduce acyclovir renal clearance.<br />Similarly increases in plasma AUCs of acyclovir and of the inactive<br />metabolite of mycophenolate mofetil, an immunosuppressant<br />agent used in transplant patients have been shown when the drugs<br />are co-administered. However no dosage adjustment is necessary<br />because of the wide therapeutic index of acyclovir.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fertility<br />See Clinical Studies in section 5.3<br />Pregnancy<br />The use of acyclovir should be considered only when the potential<br />benefits outweigh the possibility of unknown risks.<br />A post-marketing acyclovir pregnancy registry has documented<br />pregnancy outcomes in women exposed to any formulation of<br />acyclovir. The registry findings have not shown an increase in the<br />number of birth defects amongst acyclovir exposed subjects<br />compared with the general population, and any birth defects<br />showed no uniqueness or consistent pattern to suggest a common<br />cause.<br />Breast-feeding<br />Following oral administration of 200mg acyclovir five times a day,<br />acyclovir has been detected in breast milk at concentrations<br />ranging from 0.6 to 4.1 times the corresponding plasma levels.<br />These levels would potentially expose nursing infants to acyclovir<br />dosages of up to 0.3 mg/kg/day. Caution is therefore advised if<br />acyclovir is to be administered to a nursing woman.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The clinical status of the patient and the adverse event profile of<br />acyclovir should be borne in mind when considering the patient&#39;s<br />ability to drive or operate machinery. There have been no studies<br />to investigate the effect of acyclovir on driving performance or the<br />ability to operate machinery. Further, a detrimental effect on such<br />activities cannot be predicted from the pharmacology of the active<br />substance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The frequency categories associated with the adverse events below are estimates. For most events, suitable data for estimating incidence were not available. In addition, adverse events may vary in their incidence depending on the indication.</p><p>The following convention has been used for the classification of undesirable effects in terms of frequency:- Very common <!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" alt="GREATER-THAN OR EQUAL TO (8805)"
 style='width:9pt;height:9pt;mso-wrap-distance-left:1.5pt;
 mso-wrap-distance-right:1.5pt'>
 <v:imagedata src="file:///C:\Users\menna\AppData\Local\Temp\msohtmlclip1\01\clip_image001.png"
  o:href="http://renderer.medicines.org.uk/images/entities/GREATER-THAN_OR_EQUAL_TO.gif"/>
</v:shape><![endif]--><img width="15" height="15" alt="GREATER-THAN OR EQUAL TO (8805)" src="file:///C:\Users\menna\AppData\Local\Temp\msohtmlclip1\01\clip_image002.gif" />1/10, common <!--[if gte vml 1]><v:shape id="_x0000_i1026" type="#_x0000_t75" alt="GREATER-THAN OR EQUAL TO (8805)"
 style='width:9pt;height:9pt;mso-wrap-distance-left:1.5pt;
 mso-wrap-distance-right:1.5pt'>
 <v:imagedata src="file:///C:\Users\menna\AppData\Local\Temp\msohtmlclip1\01\clip_image001.png"
  o:href="http://renderer.medicines.org.uk/images/entities/GREATER-THAN_OR_EQUAL_TO.gif"/>
</v:shape><![endif]--><img width="15" height="15" alt="GREATER-THAN OR EQUAL TO (8805)" src="file:///C:\Users\menna\AppData\Local\Temp\msohtmlclip1\01\clip_image002.gif" />1/100 and &lt;1/10,<br />uncommon <!--[if gte vml 1]><v:shape id="_x0000_i1027" type="#_x0000_t75"
 alt="GREATER-THAN OR EQUAL TO (8805)" style='width:9pt;height:9pt;
 mso-wrap-distance-left:1.5pt;mso-wrap-distance-right:1.5pt'>
 <v:imagedata src="file:///C:\Users\menna\AppData\Local\Temp\msohtmlclip1\01\clip_image001.png"
  o:href="http://renderer.medicines.org.uk/images/entities/GREATER-THAN_OR_EQUAL_TO.gif"/>
</v:shape><![endif]--><img width="15" height="15" alt="GREATER-THAN OR EQUAL TO (8805)" src="file:///C:\Users\menna\AppData\Local\Temp\msohtmlclip1\01\clip_image002.gif" />1/1000 and &lt;1/100, rare <!--[if gte vml 1]><v:shape id="_x0000_i1028" type="#_x0000_t75"
 alt="GREATER-THAN OR EQUAL TO (8805)" style='width:9pt;height:9pt;
 mso-wrap-distance-left:1.5pt;mso-wrap-distance-right:1.5pt'>
 <v:imagedata src="file:///C:\Users\menna\AppData\Local\Temp\msohtmlclip1\01\clip_image001.png"
  o:href="http://renderer.medicines.org.uk/images/entities/GREATER-THAN_OR_EQUAL_TO.gif"/>
</v:shape><![endif]--><img width="15" height="15" alt="GREATER-THAN OR EQUAL TO (8805)" src="file:///C:\Users\menna\AppData\Local\Temp\msohtmlclip1\01\clip_image002.gif" />1/10,000 and &lt;1/1000, very rare &lt;1/10,000.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Blood and lymphatic system disorders:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Anaemia, leukopenia, and thrombocytopenia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Immune system disorders:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Anaphylaxis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Psychiatric and nervous system disorders:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Headache and dizziness.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Agitation, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, convulsions, somnolence, encephalopathy, coma.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>The above events are generally reversible and are usually reported in patients with renal impairment, or with other predisposing factors (see 4.4 Special Warnings and Precautions for Use).</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Respiratory, thoracic and mediastinal disorders:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Dyspnoea.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Gastrointestinal disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Nausea, vomiting, diarrhoea, and abdominal pains.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Hepato-biliary disorders</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Reversible rises in bilirubin and liver related enzymes.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Hepatitis and jaundice.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Skin and subcutaneous tissue disorders:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Pruritus and rashes (including photosensitivity).</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Urticaria. Accelerated diffuse hair loss.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Accelerated diffuse hair loss has been associated with a wide variety of disease processes and medicines, the relationship of the event to acyclovir therapy is uncertain.</p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Angioedema.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>Renal and urinary disorders:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Increases in blood urea and creatinine.</p></td></tr><tr><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Acute renal failure and renal pain.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Renal pain may be associated with renal failure and crystalluria.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong><u>General disorders and administration site conditions:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Fatigue and fever.</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>To report any side effect(s):<br /> Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222, Exts: 2317-2356-2340<br />Reporting Hotline: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br /> Other GCC States: Please contact the relevant competent<br />authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Symptoms &amp; signs: </em></strong>Acyclovir is only partly absorbed in the gastrointestinal tract. Patients have ingested overdoses of up to 20g acyclovir on a single occasion, usually without toxic effects. Accidental, repeated overdoses of oral acyclovir over several days have been associated with gastrointestinal effects (such as nausea and vomiting) and neurological effects (headache and confusion).</p><p>Overdosage of intravenous acyclovir has resulted in elevations of serum creatinine, blood urea nitrogen and subsequent renal failure. Neurological effects including confusion, hallucinations, agitation, seizures and coma have been described in association with intravenous overdosage.</p><p><strong><em>Management: </em></strong>Patients should be observed closely for signs of toxicity. Haemodialysis significantly enhances the removal of acyclovir from the blood and may, therefore, be considered a management option in the event of symptomatic overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: group Anti-infective, ATC code<br />J05AB01.<br />Mechanism of Action<br />Acyclovir is a synthetic purine nucleoside analogue with in vitro<br />and in vivo inhibitory activity against human herpes viruses,<br />including herpes simplex virus (HSV) types I and II and varicella<br />zoster virus (VZV), Epstein Barr virus (EBV) and cytomegalovirus<br />(CMV). In cell culture, acyclovir has the greatest antiviral activity<br />against HSV-1, followed (in decreasing order of potency) by HSV-2,<br />VZV, EBV and CMV.<br />The inhibitory activity of acyclovir for HSV I, HSV II, VZV, EBV and<br />CMV is highly selective. The enzyme thymidine kinase (TK) of<br />normal, non-infected cells does not use acyclovir effectively as a<br />substrate, hence toxicity to mammalian host cells is low; however,<br />TK encoded by HSV, VZV and EBV converts acyclovir to acyclovir<br />monophosphate, a nucleoside analogue which is further converted<br />to the diphosphate and finally to the triphosphate by cellular</p><p>enzymes.</p><p>Acyclovir triphosphate interferes with the viral DNA polymerase<br />and inhibits viral DNA replication with resultant chain termination<br />following its incorporation into the viral DNA.<br />Pharmacodynamic Effects<br />Prolonged or repeated courses of acyclovir in severely<br />immunocompromised individuals may result in the selection of<br />virus strains with reduced sensitivity, which may not respond to<br />continued acyclovir treatment. Most of the clinical isolates with<br />reduced sensitivity have been relatively deficient in viral TK,<br />however, strains with altered viral TK or DNA polymerase have also<br />been reported. In vitro exposure of HSV isolates to acyclovir can<br />also lead to the emergence of less sensitive strains. The<br />relationship between the in vitro-determined sensitivity of HSV<br />isolates and clinical response to acyclovir therapy is not clear.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Acyclovir is only partially absorbed from the gut. Mean steady<br />state peak plasma concentrations (Cssmax) following doses of<br />200mg acyclovir administered four-hourly were 3.1 micromolar<br />(0.7 micrograms/mL) and equivalent trough plasma levels (Cssmin)<br />were 1.8 micromolar (0.4 micrograms/mL). Corresponding Cssmax<br />levels following doses of 400 mg and 800 mg administered fourhourly<br />were 5.3 micromolar (1.2 micrograms/mL) and 8<br />micromolar (1.8 micrograms/mL) respectively, and equivalent<br />Cssmin levels were 2.7 micromolar (0.6 micrograms/mL) and 4<br />micromolar (0.9 micrograms/mL). In adults the terminal plasma<br />half-life of acyclovir after administration of intravenous acyclovir is<br />about 2.9 hours. Most of the drug is excreted unchanged by the<br />kidney. Renal clearance of acyclovir is substantially greater than<br />creatinine clearance, indicating that tubular secretion, in addition<br />to glomerular filtration, contributes to the renal elimination of the<br />drug. 9-Carboxymethoxymethylguanine is the only significant<br />metabolite of acyclovir, and accounts for approximately 10-15% of<br />the administered dose recovered from the urine. When acyclovir is<br />given one hour after 1 gram of probenecid the terminal half-life<br />and area under the plasma concentration-time curve is extended<br />by 18% and 40% respectively.<br />Elimination<br />In adults, mean Cssmax levels following a one hour infusion of 2.5<br />mg/kg, 5 mg/kg and 10mg/kg were 22.7 micromolar (5.1<br />micrograms/mL), 43.6 micromolar (9.8 micrograms/mL) and 92<br />micromolar (20.7 micrograms/mL), respectively. The<br />corresponding Cssmin levels 7 hours later were 2.2 micromolar<br />(0.5 micrograms/mL) 3.1 micromolar (0.7 micrograms/mL) and<br />10.2 micromolar (2.3 micrograms/mL), respectively. In children<br />over 1 year of age similar mean Cssmax and Cssmin levels were<br />observed when a dose of 250 mg/m2 was substituted for 5 mg/kg<br />and a dose of 500 mg/m2 was substituted for 10mg/kg. In<br />neonates and young infants (0-3 months of age) treated with doses<br />of 10 mg/kg administered by infusion over a one-hour period every<br />8 hours the Cssmax was found to be 61.2 micromolar (13.8<br />micrograms/mL) and the Cssmin to be 10.1 micromolar (2.3<br />micrograms/mL). A separate group of neonates treated with 15<br />mg/kg every 8 hours showed approximate dose proportional<br />increases, with a Cmax of 83.5 micromolar (18.8 micrograms/mL)<br />and Cmin of 14.1 micromolar (3.2 micrograms/mL). The terminal<br />plasma half-life in these patients was 3.8 hours. In the elderly total<br />body clearance falls with increasing age associated with decreases<br />in creatinine clearance although there is little change in the<br />terminal plasma half-life. In patients with chronic renal failure the<br />mean terminal half-life was found to be 19.5 hours. The mean<br />acyclovir half-life during haemodialysis was 5.7 hours. Plasma<br />acyclovir levels dropped approximately 60% during dialysis.<br />Distribution<br />Cerebrospinal fluid levels are approximately 50% of corresponding<br />plasma levels. Plasma protein binding is relatively low (9 to 33%)<br />and drug interactions involving binding site displacement are not</p><p>anticipated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fertility<br />There is no information on the effect of acyclovir oral formulations<br />or IV for infusion on human female fertility. In a study of 20 male<br />patients with normal sperm count, oral acyclovir administered at<br />doses of up to 1 g per day for up to six months has been shown to<br />have no clinically significant effect on sperm count, motility or<br />morphology.<br />Teratogenicity<br />Systemic administration of acyclovir in internationally accepted<br />standard tests did not produce embryotoxic or teratogenic effects<br />in rabbits, rats or mice. In a non-standard test in rats, foetal<br />abnormalities were observed but only following such high<br />subcutaneous doses that maternal toxicity was produced. The<br />clinical relevance of these findings is uncertain.<br />Non-Clinical Information<br />Mutagenicity<br />The results of a wide range of mutagenicity tests in vitro and in<br />vivo indicate that acyclovir is unlikely to pose a genetic risk to man.<br />Carcinogenicity<br />Acyclovir was not found to be carcinogenic in long-term studies in<br />the rat and the mouse.<br />Fertility<br />Largely reversible adverse effects on spermatogenesis in<br />association with overall toxicity in rats and dogs have been<br />reported only at doses of acyclovir greatly in excess of those<br />employed therapeutically. Two-generation studies in mice did not<br />reveal any effect of (orally administered) acyclovir on fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Inactive Ingredients:<br />1. Methyl Paraben<br />2. Propyl Paraben<br />3. Avicel RC 591<br />4. Glycerol<br />5. Sorbitol 70% Solution<br />6. Orange Banana Flavour<br />7. Purified Water</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Before opening: 24 months from the date of
manufacturing
After opening: one month

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>120mL suspension in an amber glass bottle, provided with CRC cap,<br />packed in a printed carton along with a leaflet and measuring cup.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street.
Ras Al Khaimah - United Arab Emirates.
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                06. January. 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>